// App-Quantinova.ai

e13008 : Role of different germline BRCA mutations in response to platinum-based chemotherapy in patients (pts) with triple-negative breast cancer (TNBC).

Researchers

Presenter

  • Mona Frolova

Principal Investigators

  • Ekaterina Ignatova

  • Marina B. Stenina

  • Alexander Petrovsky

  • Sergei Tjulandin

Medical Centers

  • N. N. Blokhin Russian Cancer Research Center, Moscow, Russia

  • N. N. Blokhin Russian Cancer Research Center, Moscow, Russia

  • N. N. Blokhin Russian Cancer Research Center, Moscow, Russia

Locations

  • Russia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

Biomarkers

  • BRCA mutation

Drug/Treatment

  • Doxorubicin

  • Paclitaxel

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved